![Lily Zou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lily Zou
Direktor/Vorstandsmitglied bei Glycotest, Inc.
Aktive Positionen von Lily Zou
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Glycotest, Inc.
![]() Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Lily Zou
Ehemalige bekannte Positionen von Lily Zou
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NATURE'S SUNSHINE PRODUCTS, INC. | Direktor/Vorstandsmitglied | 07.08.2019 | 20.09.2021 |
Independent Dir/Board Member | 07.08.2019 | 20.09.2021 | |
Sandoz, Inc.
![]() Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01.01.2009 | 01.01.2017 |
Fosun Pharma USA, Inc.
![]() Fosun Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Fosun Pharma USA, Inc. is a fast-growing pharmaceutical company that was founded in 2017. The private company is based in Princeton, NJ. The company, which is a subsidiary of Fosun Pharma, continually works to enhance its existing portfolio of specialty pharmaceutical injectables and to build its pipeline with both innovative and generic pharmaceutical drugs. Fosun Pharma USA is dedicated to bringing products to market to improve patient access to medicine and innovation. Rong Yang has been the CEO of the company since 2022. | Vorstandsvorsitzender | 01.02.2017 | - |
Ausbildung von Lily Zou
Cornell University | Doctorate Degree |
Beijing University of Technology | Undergraduate Degree |
MIT Sloan School of Management | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
China | 2 |
Operativ
Director/Board Member | 2 |
Independent Dir/Board Member | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NATURE'S SUNSHINE PRODUCTS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Sandoz, Inc.
![]() Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
Glycotest, Inc.
![]() Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Electronic Technology |
Fosun Pharma USA, Inc.
![]() Fosun Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Fosun Pharma USA, Inc. is a fast-growing pharmaceutical company that was founded in 2017. The private company is based in Princeton, NJ. The company, which is a subsidiary of Fosun Pharma, continually works to enhance its existing portfolio of specialty pharmaceutical injectables and to build its pipeline with both innovative and generic pharmaceutical drugs. Fosun Pharma USA is dedicated to bringing products to market to improve patient access to medicine and innovation. Rong Yang has been the CEO of the company since 2022. | Health Technology |